PHASE 1 STUDY OF GEN2, A PERSONALIZING SYSTEMIC CANCER IMMUNOTHERAPY, IN ADULT PATIENTS WITH ADVANCED SOLID TUMOR MALIGNANCIES

Authors
Category Primary study
Conference40th Annual Meeting of Society for Immunotherapy of Cancer, SITC 2025
Year 2025
This article has no abstract
Epistemonikos ID: 0334d7f142e2cd3739c0460b1f42ca05987cee8d
First added on: Dec 12, 2025